Cargando…
Repurposing calcium-sensing receptor agonist cinacalcet for treatment of CFTR-mediated secretory diarrheas
Diarrhea is a major cause of global mortality, and outbreaks of secretory diarrhea such as cholera remain an important problem in the developing world. Current treatment of secretory diarrhea primarily involves supportive measures, such as fluid replacement. The calcium-sensing receptor (CaSR) regul...
Autores principales: | Oak, Apurva A., Chhetri, Parth D., Rivera, Amber A., Verkman, Alan S., Cil, Onur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934922/ https://www.ncbi.nlm.nih.gov/pubmed/33400691 http://dx.doi.org/10.1172/jci.insight.146823 |
Ejemplares similares
-
Plumbagin Prevents Secretory Diarrhea by Inhibiting CaCC and CFTR Channel Activities
por: Yu, Bo, et al.
Publicado: (2019) -
Pro-Secretory Activity and Pharmacology in Rabbits of an Aminophenyl-1,3,5-Triazine CFTR Activator for Dry Eye Disorders
por: Felix, Christian M., et al.
Publicado: (2017) -
SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine
por: Cil, Onur, et al.
Publicado: (2021) -
CFTR Activator Increases Intestinal Fluid Secretion and Normalizes Stool Output in a Mouse Model of Constipation
por: Cil, Onur, et al.
Publicado: (2016) -
Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions
por: Li, Chunying, et al.
Publicado: (2005)